包括利益、他勘定振替高（薬品）
- 【期間】
| 年度 | 包括利益 | 他勘定振替高（薬品） |
|---|
| 2010/06 | 15.5億 | | - | |
| 2010/09 | 24.2億 | +56.6% | - | |
| 2010/12 | 53.2億 | +119.7% | - | |
| 2011/03 | 67.1億 | +26.1% | - | |
| 2011/06 | 23億 | -65.7% | - | |
| 2011/09 | 29億 | +26% | - | |
| 2011/12 | 31.5億 | +8.7% | - | |
| 2012/03 | 69.6億 | +121% | 88百万 | |
| 2012/06 | 31.1億 | -55.4% | - | |
| 2012/09 | 36億 | +15.9% | - | |
| 2012/12 | 75.6億 | +110% | - | |
| 2013/03 | 147億 | +94.3% | 63百万 | -28.4% |
| 2013/06 | 62.4億 | -57.6% | - | |
| 2013/09 | 112億 | +79.1% | - | |
| 2013/12 | 150億 | +34.5% | - | |
| 2014/03 | 191億 | +27.3% | - | |
| 2014/06 | 29.2億 | -84.7% | - | |
| 2014/09 | 57.7億 | +97.3% | - | |
| 2014/12 | 135億 | +134.6% | - | |
| 2015/03 | 220億 | +62.5% | - | |
| 2015/06 | 30.6億 | -86.1% | - | |
| 2015/09 | 35.7億 | +16.8% | - | |
| 2015/12 | 51.3億 | +43.6% | - | |
| 2016/03 | 47.7億 | -7% | - | |
| 2016/06 | -8.74億 | 赤転 | - | |
| 2016/09 | -11.4億 | 赤拡 | - | |
| 2016/12 | 54億 | 黒転 | - | |
| 2017/03 | 144億 | +167.8% | - | |
| 2017/06 | 44.4億 | -69.3% | - | |
| 2017/09 | 113億 | +154.8% | - | |
| 2017/12 | 185億 | +63.4% | - | |
| 2018/03 | 203億 | +9.6% | - | |
| 2018/06 | 5.95億 | -97.1% | - | |
| 2018/09 | 43.2億 | +626.6% | - | |
| 2018/12 | 61.2億 | +41.6% | - | |
| 2019/03 | 80億 | +30.7% | - | |
| 2019/06 | 44.1億 | -44.9% | - | |
| 2019/09 | 57.2億 | +29.7% | - | |
| 2019/12 | 99.2億 | +73.6% | - | |
| 2020/03 | 95.6億 | -3.6% | - | |
| 2020/06 | -2.71億 | 赤転 | - | |
| 2020/09 | 38.6億 | 黒転 | - | |
| 2020/12 | 84.8億 | +119.7% | - | |
| 2021/03 | 134億 | +57.9% | - | |
| 2021/06 | 55.9億 | -58.2% | - | |
| 2021/09 | 100億 | +79.3% | - | |
| 2021/12 | 108億 | +7.5% | - | |
| 2022/03 | 154億 | +42.6% | - | |
| 2022/06 | 59.2億 | -61.5% | - | |
| 2022/09 | 131億 | +120.9% | - | |
| 2022/12 | 172億 | +31.8% | - | |
| 2023/03 | 170億 | -1.2% | - | |
| 2023/06 | 63.6億 | -62.7% | - | |
| 2023/09 | 146億 | +129.4% | - | |
| 2023/12 | 203億 | +39.2% | - | |
| 2024/03 | 296億 | +45.5% | - | |
| 2024/06 | 58.6億 | -80.2% | - | |
